Open Access Open Access  Restricted Access Subscription Access

A Specific Parameters of Lung Cancer Include Evaluation and Treatment

Mahapatra APK, Srinivas G., Ramanjaneyulu D. V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, R. Faith Rani, P. Megha Varna, K. Sridevi

Abstract


Bronchogenic carcinoma, often known as lung cancer, is linked to tumours that start in the bronchi or lung parenchyma. It is among the main reasons why people in the US die from cancer. Since 1987, lung cancer has claimed more lives in women than breast cancer combined. An estimated 160,000 people in the US lose their lives to lung cancer each year, and there are an estimated 225,000 new instances of the disease. Interestingly, until the start of the 20th century, lung cancer was a rather uncommon illness. The primary cause of its sharp increase in later decades is an improvement in smoking rates among both men and women. This exercise stresses the importance of the interprofessional team in managing lung cancer and provides information on its causes, pathophysiology, and presentation.

Full Text:

PDF

References


Decker DA, Dines DE, Payne WS, Bernatz PE, Pairolero PC. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest. 1978 Dec;74(6):640-2.

Maskell NA, Butland RJ., Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003 May;58 Suppl 2(Suppl 2):ii8-17.

Rahman NM, Ali NJ, Brown G, Chapman SJ, Davies RJ, Downer NJ, Gleeson FV, Howes TQ, Treasure T, Singh S, Phillips GD., British Thoracic Society Pleural Disease Guideline Group. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii54-60.

The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol. 2006 Jul;59(1):93-103.

Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003 Jan;123(1 Suppl):137S-146S.

Schumacher T, Brink I, Mix M, Reinhardt M, Herget G, Digel W, Henke M, Moser E, Nitzsche E. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med. 2001 Apr;28(4):483-8.

Erasmus JJ, Patz EF, McAdams HP, Murray JG, Herndon J, Coleman RE, Goodman PC. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997 May;168(5):1357-60.

Doyle TJ. Brain metastasis in the natural history of small-cell lung cancer: 1972-1979. Cancer. 1982 Aug 15;50(4):752-4.

Hiraki A, Ueoka H, Takata I, Gemba K, Bessho A, Segawa Y, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M. Hypercalcemia-leukocytosis syndrome associated with lung cancer. Lung Cancer. 2004 Mar;43(3):301-7.

Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007 May 04;2:22.


Refbacks

  • There are currently no refbacks.